BTM-27253-33427 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Dose 1 — Pfizer-BioNTech
2021-01-12
Registered in v-safe
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-12
Health check-in — day 0, dose 2
Feeling: Fair · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-15
Survey response — days 1–6 daily, dose 2
MedDRA: Lymph node pain — Feeling: Good · Site: Pain · Muscle or body aches

Free text: Underarm tenderness on the side of the injection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-20
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-02
Survey response — day 21, dose 2
MedDRA: Psoriasis — Feeling: Good

Free text: Psoriasis

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-09
Survey response — day 28, dose 2
MedDRA: Pre-existing disease, Psoriasis — Feeling: Good

Free text: Psoriasis flare up

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-16
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-23
Survey response — day 42, dose 2
MedDRA: Pre-existing disease, Psoriasis — Feeling: Fair

Free text: Continued and worsening psoriasis outbreak

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-13
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-12
Survey response — 12 months, dose 2
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Covid positive 12/22/21

MedDRA releases: 2024-11 · check-in free text available
2022-01-12
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-14
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-15

Systemic reaction (other): Underarm tenderness on the side of the injection

Release 3 — day 21, dose 2

2021-02-02

Symptoms: Psoriasis

Release 3 — day 28, dose 2

2021-02-09

Symptoms: Psoriasis flare up

Release 4 — day 42, dose 2

2021-02-23

Symptoms: Continued and worsening psoriasis outbreak

Release 10 — 12 months, dose 2

2022-01-12

Symptoms: Covid positive 12/22/21

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	Psoriasis	✓	✓	✓
SRO	Lymph node pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release